Companies in #Glioblastoma (GBM)
Found 1 company operating in this sector.
Novocure (NASDAQ: NVCR) is an oncology medical-device company pioneering Tumor Treating Fields (TTFields), a non-invasive, antimitotic therapy delivered via wearable transducer arrays. Approved for glioblastoma (Optune Gio) and malignant pleural mesothelioma, with active programs in non-small cell lung cancer, pancreatic cancer, brain metastases, and ovarian cancer.